Paloma Partners’s Acorda Therapeutics, Inc. ACOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-1,990
| Closed | -$175K | – | 2317 |
|
|
2020
Q2 | $175K | Buy |
+1,990
| New | +$175K | ﹤0.01% | 1578 |
|
|
2020
Q1 | – | Sell |
-583
| Closed | -$143K | – | 1929 |
|
|
2019
Q4 | $143K | Buy |
583
+110
| +23% | +$27K | ﹤0.01% | 1717 |
|
|
2019
Q3 | $163K | Buy |
+473
| New | +$163K | ﹤0.01% | 1459 |
|
|
2018
Q4 | – | Sell |
-185
| Closed | -$436K | – | 1473 |
|
|
2018
Q3 | $436K | Buy |
+185
| New | +$436K | 0.01% | 819 |
|
|
2017
Q1 | – | Sell |
-323
| Closed | -$729K | – | 1740 |
|
|
2016
Q4 | $729K | Buy |
323
+144
| +80% | +$325K | 0.01% | 923 |
|
|
2016
Q3 | $448K | Sell |
179
-56
| -24% | -$140K | 0.01% | 1012 |
|
|
2016
Q2 | $719K | Buy |
235
+34
| +17% | +$104K | 0.01% | 949 |
|
|
2016
Q1 | $637K | Buy |
+201
| New | +$637K | 0.01% | 827 |
|
|
2015
Q4 | – | Sell |
-76
| Closed | -$243K | – | 1608 |
|
|
2015
Q3 | $243K | Buy |
+76
| New | +$243K | 0.01% | 1066 |
|
|
2015
Q2 | – | Sell |
-75
| Closed | -$299K | – | 1744 |
|
|
2015
Q1 | $299K | Buy |
+75
| New | +$299K | 0.01% | 855 |
|
|
2014
Q4 | – | Sell |
-140
| Closed | -$568K | – | 1307 |
|
|
2014
Q3 | $568K | Buy |
+140
| New | +$568K | 0.03% | 442 |
|